杨敏凤
博士，副教授，硕士研究生导师
Email: 2024089@ntu.edu.cn
杨敏凤，2023年博士毕业于香港理工大学，同年拿到香港理工大学助理教授（研究）的正式教职，并获得香港理工大学助理教授（研究）科研启动资金资助。主要从事活体分子影像，肿瘤免疫微环境，肿瘤血管，以及新型硼药用于硼中子俘获治疗相关工作。作为第一或通讯作者在国际知名学术期刊 Journal for ImmunoTherapy of Cancer、Cell Death& Disease、Journal of Translational Medicine等发表论文13篇。主持教育部、省市级项目4项。
招生方向
公共卫生与预防医学，公共卫生，卫生检验，医学检验技术。
承担项目
1. 教育部博士后海外引才专项（2024），主持
2. 江苏省自然科学基金青年基金（2025），主持
3. 江苏省卓越博士后计划（2025），主持
4. 南通市自然基金青年项目（2024），主持
5. 香港理工大学助理教授（研究）科研启动经费（2023），主持
6. 香港理工大学校级基金Seed fund（2023），主持
7. 南通大学人才引进项目（科研启动经费）（2024），主持
8. 南通大学大型仪器设备开放基金（2026），主持
代表论文
1. Yang, M., Mahanty, A., Jin, C., Wong, A. N. N., & Yoo, J. S. (2022). Label-free metabolic imaging for sensitive and robust monitoring of anti-CD47 immunotherapy response in triple-negative breast cancer. Journal for immunotherapy of cancer, 10(9), e005199.
2. Yang, M., Hou, S., Chen, Y., Chen, H., Chu, M., & Liu, S. B. (2025). Emerging insights into intravital imaging, unraveling its role in cancer immunotherapy. Cancer Immunology, Immunotherapy, 74(3), 100.
3. Bao, X., Chen, Y., Chang, J., Du, J., Yang, C., Wu, Y., ... Yang, M* & Liu, S. B*. (2025). Machine learning-based bulk RNA analysis reveals a prognostic signature of 13 cell death patterns and potential therapeutic target of SMAD3 in acute myeloid leukemia. BMC cancer, 25(1), 273.
4. Gu, Q., Li, S., Hou, S., Liu, J., Zhang, X., Xi, Y., ... & Yang, M*. (2026). Antibody-dependent cellular phagocytosis in cancer immunotherapy: research and perspectives. Journal of Translational Medicine.
5. Guan, J.,Jiang, Xu., Lv Yi., Xue Ya., Zhang Jing., Ji Hai., ...Yang, M*., & Wang, Qi. (2026). Visualizing NO2-/NAD(P)H metabolic crosstalk in E. coli-infected bladder cancer via a dual-responsive probe. Chemical Communications.
6. Chen, Y., Li, X., Yang, M*., & Liu, S. B*. (2024). Research progress on morphology and mechanism of programmed cell death. Cell death & disease, 15(5), 327.
7. Jin, C., Lu, X., Yang, M*., & Hou, S*. (2024). Integrative analysis indicates the potential values of ANKRD53 in stomach adenocarcinoma. Discover oncology, 15(1), 188.
8. Li, X., Li, S., Li, D., Xi, Y., Gu, Q., Liu, J., ... Yang, M* & Chu, M*. (2026). Glycolytic Signaling Pathways and Anti‐Glycolytic Therapy for Cancer: Research and Perspectives. Comprehensive Physiology, 16(3), e70177.
9. Xi, Y., Yan, X., Liu, J., Li, S., Zhang, X., Hou, Y., ... & Yang, M*. (2026). Methodological Landscape of DNA Damage Response Detection: From Conventional Assays to Future Innovations. Current Issues in Molecular Biology, 48(4), 339.
10. Jin, C#., Yang, M#., Han, X., Chu, H., Zhang, Y., Lu, M., Wang, Z., Xu, X., Liu, W., Wang, F., & Ju, S. (2019). Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125. Journal of Ovarian Research, 12(1), 1–8. https://doi.org/10.1186/s13048-019-0587-0
11. Bao, Y#., Yang, M#., Jin, C., Hou, S., Shi, B., Shi, J., & Lin, N. (2018). Preoperative Hematologic Inflammatory Markers as Prognostic Factors in Patients with Glioma.World Neurosurgery, 119, e710–e716. https://doi.org/10.1016/j.wneu.2018.07.252
12. Yang, M., Oh, I. Y., Mahanty, A., Jin, W. L., & Yoo, J. S. (2020). Immunotherapy for glioblastoma: Current state, challenges, and future perspectives. Cancers, 12(9), 1–23. https://doi.org/10.3390/cancers12092334.
获奖情况
1. 2023年核医学分子影像学会最佳摘要奖
2. 2023年香港理工大学优秀博士学位论文奖
3. 2021年世界分子影像大会女性分子影像学者奖
4. 第四届全国职业院校“华教杯”教师检验技能竞赛三等奖
